These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29314393)

  • 21. White matter hyperintensities are related to pain intensity in an outpatient memory clinic population: preliminary findings.
    Binnekade TT; Perez RS; Maier AB; Rhodius-Meester HF; Legdeur N; Trappenburg MC; Rhebergen D; Lobbezoo F; Scherder EJ
    J Pain Res; 2019; 12():1621-1629. PubMed ID: 31190972
    [No Abstract]   [Full Text] [Related]  

  • 22. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.
    Spilling CA; Jones PW; Dodd JW; Barrick TR
    BMC Pulm Med; 2017 Jun; 17(1):92. PubMed ID: 28629404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.
    Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L
    Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain atrophy and white-matter hyperintensities are not significantly associated with incidence and severity of postoperative delirium in older persons without dementia.
    Cavallari M; Hshieh TT; Guttmann CR; Ngo LH; Meier DS; Schmitt EM; Marcantonio ER; Jones RN; Kosar CM; Fong TG; Press D; Inouye SK; Alsop DC;
    Neurobiol Aging; 2015 Jun; 36(6):2122-9. PubMed ID: 25824618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study.
    Legdeur N; Badissi M; Yaqub M; Beker N; Sudre CH; Ten Kate M; Gordon MF; Novak G; Barkhof F; van Berckel BNM; Holstege H; Muller M; Scheltens P; Maier AB; Visser PJ
    J Gerontol B Psychol Sci Soc Sci; 2021 Sep; 76(8):1499-1511. PubMed ID: 32898275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer's disease.
    Cheng YW; Chen TF; Cheng TW; Lai YM; Hua MS; Chen YF; Chiu MJ
    Alzheimers Res Ther; 2015 Nov; 7():72. PubMed ID: 26592961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Pantoni L; Basile AM; Inzitari D; Erkinjuntti T; Wahlund LO; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1497-500. PubMed ID: 16227537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
    Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
    Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual rating of the hippocampus in non-demented elders: Does it measure hippocampal atrophy or other indices of brain atrophy? The SMART-MR study.
    Knoops AJ; van der Graaf Y; Appelman AP; Gerritsen L; Mali WP; Geerlings MI
    Hippocampus; 2009 Nov; 19(11):1115-22. PubMed ID: 19253411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
    Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
    Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.
    Kaipainen AL; Pitkänen J; Haapalinna F; Jääskeläinen O; Jokinen H; Melkas S; Erkinjuntti T; Vanninen R; Koivisto AM; Lötjönen J; Koikkalainen J; Herukka SK; Julkunen V
    Neuroradiology; 2021 Dec; 63(12):2035-2046. PubMed ID: 34389887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 37. Posterior white matter hyperintensities are associated with reduced medial temporal lobe subregional integrity and long-term memory in older adults.
    Rizvi B; Sathishkumar M; Kim S; Márquez F; Granger SJ; Larson MS; Miranda BA; Hollearn MK; McMillan L; Nan B; Tustison NJ; Lao PJ; Brickman AM; Greenia D; Corrada MM; Kawas CH; Yassa MA
    Neuroimage Clin; 2023; 37():103308. PubMed ID: 36586358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.
    Caroli A; Testa C; Geroldi C; Nobili F; Guerra UP; Bonetti M; Frisoni GB
    J Neurol; 2007 Aug; 254(8):1000-8. PubMed ID: 17375260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of Brain Perfusion with White Matter Hyperintensity, Brain Atrophy, and Cognition in Patients with Posterior Cerebral Artery Stenosis and Subjective Cognitive Decline.
    Liu M; Nie ZY; Li RR; Zhang W; Wang H; He YS; Zhao LJ; Li YX
    Med Sci Monit; 2018 Aug; 24():5729-5738. PubMed ID: 30115900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.